Cargando…
Neuroplastin 65 deficiency reduces amyloid plaque formation and cognitive deficits in an Alzheimer’s disease mouse model
INTRODUCTION: Alzheimer’s disease (AD) is characterized by increasing cognitive dysfunction, progressive cerebral amyloid beta (Aβ) deposition, and neurofibrillary tangle aggregation. However, the molecular mechanisms of AD pathologies have not been completely understood. As synaptic glycoprotein ne...
Autores principales: | Wu, Dan-Dan, Cheng, Jie, Zheng, Ya-Ni, Liu, Yu-Tong, Hou, Shuang-Xin, Liu, Li-Fen, Huang, Liang, Yuan, Qiong-Lan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10196121/ https://www.ncbi.nlm.nih.gov/pubmed/37213217 http://dx.doi.org/10.3389/fncel.2023.1129773 |
Ejemplares similares
-
Increased Susceptibility to Ischemic Brain Injury in Neuroplastin 65-Deficient Mice Likely via Glutamate Excitotoxicity
por: Hu, Yuhui, et al.
Publicado: (2017) -
Neuroplastin in Neuropsychiatric Diseases
por: Lin, Xiao, et al.
Publicado: (2021) -
Microarray Analysis of Gene Expression Changes in Neuroplastin 65-Knockout Mice: Implications for Abnormal Cognition and Emotional Disorders
por: Li, Huanhuan, et al.
Publicado: (2018) -
Hippocampal expression of cell‐adhesion glycoprotein neuroplastin is altered in Alzheimer's disease
por: Ilic, Katarina, et al.
Publicado: (2018) -
Neuroplastin Modulates Anti-inflammatory Effects of MANF
por: Yagi, Takuya, et al.
Publicado: (2020)